Neuroinflammation

Neuroinflammation is a defensive response, characterized by the activation of proinflammatory molecules including microglia and astrocytes. The response has been implicated in brain injuries, acute and chronic neurological and neurodegenerative disorders such as Alzheimer’s disease. Here is the latest research on neuroinflammation.

September 17, 2020

Astrocyte remodeling in the beneficial effects of long-term voluntary exercise in Alzheimer's disease

Journal of Neuroinflammation
Irina BelayaKatja M Kanninen
September 17, 2020
Review
Open Access

Pathomechanisms of Non-Traumatic Acute Brain Injury in Critically Ill Patients

Medicina
Wojciech DabrowskiKatarzyna Kotfis
September 17, 2020
Review
Open Access

Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review

Journal of Clinical Medicine
Gjumrakch AlievCecil E Kirkland
September 16, 2020
Review
Open Access

Alzheimer's disease: natural products as inhibitors of neuroinflammation

Inflammopharmacology
Olumayokun A Olajide, Satyajit D Sarker
September 17, 2020

A case of CIDP concurrent with MGUS IgG kappa responsive to autologous stem cell transplantation

Neurology. Neuroimmunology and Neuroinflammation
Giuseppe ColucciClaudio Gobbi
September 17, 2020

Changes of Serum Inflammatory Molecules and Their Relationships with Visual Function in Retinitis Pigmentosa

Investigative Ophthalmology & Visual Science
Ayako OkitaKoh-Hei Sonoda
September 18, 2020

Rps27a might act as a controller of microglia activation in triggering neurodegenerative diseases

PloS One
Nasibeh KhayerMaryam Jalessi
September 18, 2020
Open Access

Circulating MicroRNAs in Extracellular Vesicles as Potential Biomarkers of Alcohol-Induced Neuroinflammation in Adolescence: Gender Differences

International Journal of Molecular Sciences
Francesc IbáñezMaría Pascual
September 17, 2020
Open Access

Altered Secretome and ROS Production in Olfactory Mucosa Stem Cells Derived from Friedreich's Ataxia Patients

International Journal of Molecular Sciences
Sara Pérez-LuzJavier Díaz-Nido
September 18, 2020
Preprint

Drug library screen identifies inhibitors of toxic astrogliosis

MedRxiv : the Preprint Server for Health Sciences
R. R. MasvekarBibiana Bielekova
September 16, 2020

Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Patrick T Ronaldson, Thomas P Davis
September 16, 2020
Comment / Editorial
Open Access

Is CSF neurofilament light chain measurement relevant for MS?

Neurology. Neuroimmunology and Neuroinflammation
Makoto Matsui
September 17, 2020

Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody

Neurology. Neuroimmunology and Neuroinflammation
Keisuke YoshikawaSusumu Kusunoki

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuroinflammation/a62227c7-9eb8-4ec9-9490-02777a7468a8